Accuray Incorporated is committed to providing an improved quality of life and a non-surgical treatment option for those diagnosed with cancer. We strive to achieve this goal by supporting well designed clinical research in a variety of pathology specific applications.
Accuray is sponsoring several clinical studies that are currently enrolling patients; these are listed below. Click on the National Institute of Health links for complete information on each study. To contact Accuray to learn more about participating as a patient or as a clinician in any of our open clinical studies, click the e-mail link below for the appropriate study or call +1.408.789.4301 or toll free +1.888.522.3740 x4301.
The PACE Study: A randomized study comparing surgery, CyberKnife and conventional radiation therapy for early stage prostate cancer (identifier: NCT01584258)- Click here to visit the website.
To email someone with Accuray about this study, click here.